Sherwin Sells 30,000 Shares STALICLA signs agreement with Novartis on neurodevelopmental disorders Call

When a system approaches full allosteric occupancy, the Schild plot curves and the slope falls below

publications : AlphaFold3 benchmarking for GPCRs; new structural insights into peptide ligand activation All Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ Already a Premium

Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific Outputs Call

No one person can be excellent at all of it — and pretending otherwise slows discovery. about trust — the kind of trust built when collaborators confirm your data, replicate your results, and call

Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would you want to miss out on all As a premium member , you have access to all the complimentary perks as well as: Dr. GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted

stable, are believed to influence the function and regulation of GPCRs—a process known as receptor cross-talk

orthosteric and allosteric interactions as interchangeable, you’re leaving precision (and money) on the table

The donors act as light-harvesting antennas, capturing light from all directions, unlike the dipole-dipole This has been done in assays tracking IP1 and cAMP to detect biased agonism in GPCR ligands Table 1.

Drug pipelines live and die by your ability to make fast, accurate calls. A renin inhibitor that lowers blood pressure in healthy volunteers might not drop blood pressure at all Reflexes as Drug Design Partners Not all reflexes are enemies. Some can make a mediocre drug shine. Ligands come and go, feedback loops kick in, and what you see in vitro rarely tells the whole story.

A compound shows no response in one assay, and we call it “selective.”

You can now watch the live talk recordings from the previous symposiums, check them out here.

GPCR University offers two live courses this fall that you won’t want to miss.

Industry News Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May Beat Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all

interactions of the serotonin1A receptor Industry News Neurocrine Biosciences Announces Conference Call

You can find more information about them on the Live Talks page and mark your calendar HERE.

development of cachexia therapeutics Sosei Heptares Webinar Presentation for FY2022 Financial Results Call

Premium members can always go back and watch the recorded talks at any time. Submit a 1-minute abstract video and tell us more about your project in this form.

GPCR Ecosystem this fall.

Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights Call for GPCR Papers GPCRs: Signal

collaborations GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma Call

Nouvelle-Aquitaine Region Governor GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

With just one week left, becoming a premium member is all it takes to benefit from this discount! Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Call

The on-rate/off-rate balance  matters: too tight, and penetration stalls; too loose, and efficacy dissipates Washout experiments don’t tell the full story.

Submit poster abstracts via this form; short talks will be selected.

Submit poster abstracts using this form; short talks will be selected from submissions.

Artificial Intelligence for Drug Discovery Call for GPCR Papers GPCRs: Signal Transduction.

Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech companies to discover in western in 2023 Call

The program is under construction but if you’d like to give a talk or present a poster, email us at Hello

Call for GPCR Papers GPCRs: Signal Transduction. Ends tomorrow - March 31st, 2023.